Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Betschel

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Plos One|November 16, 2023
Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registryArmin Abadeh, Sarah Shehadeh, Stephen Betschel, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 25, 2017
Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36Nina Lakhani Jindal, Elaine Harniman, Nieves Prior, et al.
Pathogens & Immunity|January 6, 2022
Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID)Wei Zhan, Todd Hatchette, Fengyun Yue, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2019
Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergyBaruch D Jakubovic, Amanda Jagdis, Martina Trinkaus, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 23, 2021
Demographic and clinical characteristics of patients with hereditary angioedema in CanadaErika Yue Lee, Jane Hsieh, Teresa Caballero, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 15, 2021
Quality of life in patients with hereditary angioedema in CanadaErika Yue Lee, Jane Hsieh, Rozita Borici-Mazi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|November 28, 2018
The diagnosis of hereditary angioedema with C1 inhibitor deficiency: a survey of Canadian physicians and laboratoriesXavier Charest-Morin, Stephen Betschel, Rozita Borici-Mazi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 28, 2024
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in CanadaAdil Adatia, Jean-Nicolas Boursiquot, Dawn Goodyear, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2019
Development of the Hereditary Angioedema Rapid Triage ToolStephen Betschel, Ernie Avilla, Amin Kanani, et al.
Clinical Immunology (Orlando, Fla.)|December 9, 2019
Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapyEyal Grunebaum, Brenda Reid, Ahmed Naqvi, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Plos One|November 16, 2023
Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registryArmin Abadeh, Sarah Shehadeh, Stephen Betschel, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 25, 2017
Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36Nina Lakhani Jindal, Elaine Harniman, Nieves Prior, et al.
Pathogens & Immunity|January 6, 2022
Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID)Wei Zhan, Todd Hatchette, Fengyun Yue, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2019
Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergyBaruch D Jakubovic, Amanda Jagdis, Martina Trinkaus, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 23, 2021
Demographic and clinical characteristics of patients with hereditary angioedema in CanadaErika Yue Lee, Jane Hsieh, Teresa Caballero, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 15, 2021
Quality of life in patients with hereditary angioedema in CanadaErika Yue Lee, Jane Hsieh, Rozita Borici-Mazi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|November 28, 2018
The diagnosis of hereditary angioedema with C1 inhibitor deficiency: a survey of Canadian physicians and laboratoriesXavier Charest-Morin, Stephen Betschel, Rozita Borici-Mazi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 28, 2024
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in CanadaAdil Adatia, Jean-Nicolas Boursiquot, Dawn Goodyear, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2019
Development of the Hereditary Angioedema Rapid Triage ToolStephen Betschel, Ernie Avilla, Amin Kanani, et al.
Clinical Immunology (Orlando, Fla.)|December 9, 2019
Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapyEyal Grunebaum, Brenda Reid, Ahmed Naqvi, et al.
Pageof 4